Recently, Nicholas Weston Lawyers was the lanyard sponsor of Australia’s first Tech Transfer Summit (TTS), a two-day program of insight into and discussion of early stage biopharma innovation, technology transfer, negotiations, partnering, licensing, industry-research collaborations, and — for those who brought their microscopes — Australian venture capital.
TTS Australia 2013 was held with the assistance of AusBiotech at the Walter & Eliza Hall Institute (WEHI) of Medical Research, Melbourne, from 3 – 4 September 2013 and is one chapter of a global initiative with other summits in Asia, Europe and North America designed to help build the expertise and relationships that enable successful tech transfer deals.
Earlier this year, Nicholas Weston acted as AusIndustry‘s Biotechnology Sectoral Intermediary in the consultative process that underpinned development of the R&D Tax Incentive Biotechnology Sectoral Guide released in April and so we were most interested to hear various takes and pitches relating to the scheme.
International delegates travelled from the Johns Hopkins University, Baltimore, the University of California, San Francisco, BIO Ventures for Global Health, and New Zealand. It was great to see attendees from Australia from all areas of tech transfer including universities, medical research institutes, investors as well as early-stage biotechs.
The firm was delighted to support the TTS initiative. As probably the only law firm in Australia owned by a lawyer who has actually operates a listed public biotechnology company, our firm has earned a seat at the table because we know what it takes to advance an enterprise in the ‘new-normal’ world. We help life sciences companies in nearly every aspect of their business and operations. Don’t hesitate to get in touch and see how we could help yours.
For more information contact Viktoriia Hristova on:
(+61) 1300 132 551 or request a call back by emailing firstname.lastname@example.org
- 25 Sep, 2013
- Posted by Nicholas Weston
- 0 Comments